NOT JUST ANALYTICS. IT'S BIOPROGNOSIS.
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Jan 2024)
What this means for you
This application is over — abandoned 01 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97145964
- Mark type
- Stylized text
- Filed
- 29 Nov 2021
- Published for opposition
- 31 May 2022
- Abandoned
- 01 Jan 2024
- Attorney of record
- Susan Piascik Christoff
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic blood testing reagents and assays for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in kidney, heart, and liver health testing and disease prediction
- Class 010 — Medical apparatus: Blood test collection kit comprised of blood collection bag, holder for medical sample tubes, vials, and test trips, and medical sample tubes, vials, and test strips for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health
- Class 041 — Education and entertainment services: Providing online journals, namely, blogs in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, liver health, liver diseases, heart health, heart diseases, and the use of artificial intelligence for medical analysis; entertainment, information, and education services, namely, providing podcasts in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, liver health, liver disease treatments, heart health, heart disease treatments, and the use of artificial intelligence for medical analysis; video production; arranging and conducting of conferences, symposia, and educational special events in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, liver health, liver disease treatments, heart health, heart disease treatments, and the use of artificial intelligence for medical analysis; Educational services, namely, conducting informal on-line programs in the fields of health and medical information, kidney health, kidney disease, kidney disease treatments, liver health, liver disease treatments, heart health, heart disease treatments, and the use of artificial intelligence for medical analysis, and printable materials distributed therewith
- Class 042 — Scientific and technological services: Development of new technology for others in the field of medical devices and medical diagnostic apparatuses for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney, heart, and liver health and kidney, heart, and liver diseases; medical research services relating to kidney, heart, and liver health; research and development services in the field of antibodies relating to kidney, heart, and liver health; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis in the field of kidney, heart, and liver health and kidney, heart, and liver disease
- Class 044 — Medical, beauty and agricultural services: Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with kidney, heart, and liver health and kidney, heart, and liver disease
Owner
- Renalytix AI, Inc., New York, NY, US
- Renalytix AI, Inc., New York, NY, US
Prosecution history
- 02 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 13 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 May 2023 — SOU EXTENSION 1 GRANTED
- 11 May 2023 — SOU EXTENSION 1 FILED
- 11 May 2023 — SOU TEAS EXTENSION RECEIVED
- 29 Nov 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Oct 2022 — NEW NOA TO ISSUE
- 26 Jul 2022 — NOTICE OF ALLOWANCE CANCELLED
- 28 Jul 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 May 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 May 2022 — PUBLISHED FOR OPPOSITION
- 11 May 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Apr 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Apr 2022 — EXAMINER'S AMENDMENT ENTERED